ß-galactocerebrosidase (galc) Newborn Screening Test System

Device Code: 682

Product Code(s): QCM

Definition: For Quantitative Measurement Of The Activity Of ß-galactocerebrosidase (GALC) From Newborn Dried Blood Spot Specimens As An Aid In Screening Newborns For Krabbe Disease.

Device Classification Information

Device Type ID682
Device Nameß-galactocerebrosidase (galc) Newborn Screening Test System
Physical StateNeonatal Screening Test, In Vitro Diagnostic Device.
Technical MethodQuantitative Enzymatic Activity Assay.
Target AreaNewborn Dried Blood Spot Specimens.
Regulation Medical SpecialtyClinical Chemistry
Review PanelClinical Chemistry
Submission Type510(k)
CFR Regulation Number862.1488 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodeQCM
GMP ExemptNo
Summary MRIneligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID682
Deviceß-galactocerebrosidase (galc) Newborn Screening Test System
Product CodeQCM
FDA Device ClassificationClass 2 Medical Device
CFR Regulation Number862.1488 [🔎]
TPLC Last Update: 2019-04-02 19:38:37

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.